2-(2-nitrobenzyl)isoindoline-1,3-dione | 35970-03-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 英文名称: 2-(2-nitrobenzyl)isoindoline-1,3-dione
• 英文别名: N-(2-nitrophenylmethyl)phthalimide；N-(ortho-nitrobenzyl)-phthalimide；N-(o-nitrobenzyl)-phtalimide；o-nitrobenzylphthalimide；N-o-nitrobenzyl-phthalimide；N-(2-nitro-benzyl)-phthalimide；2-[(2-Nitrophenyl)methyl]isoindole-1,3-dione
• CAS: 35970-03-7
• 化学式: C₁₅H₁₀N₂O₄
• 分子量: 282.255
• InChiKey: WKFJHWYASVXANA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  21
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  83.2
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(2-nitrobenzyl)isoindoline-1,3-dione 在 甲醇 、 sodium tetrahydroborate 、 copper(II) bis(trifluoromethanesulfonate) 、 sodium carbonate 作用下， 以 四氢呋喃 、 水 、 1,2-二氯乙烷 、 乙腈 为溶剂， 反应 9.17h， 生成 3-苯基-2,3-二氢异吲哚-1-酮
  参考文献：
  名称：

  铜催化的C（sp 3）–OH裂解及伴随的C–C偶联：3取代异吲哚啉酮的合成

  摘要：

  三氟甲磺酸铜（II）（Cu（OTf）2）有效催化3-羟基异吲哚满酮与各种芳基，杂芳基和烯基硼酸的CC偶联，提供C（3）芳基，杂芳基和烯基取代的异吲哚啉酮。偶联反应在1,2-二氯乙烷（DCE）回流中能顺利进行，从而影响分子间和分子内两种形式。这是有关C（sp 3）-OH裂解并伴随C-C偶联的第一个报告。光不稳定的2-硝基苄基保护基最适合于促进偶联反应和脱保护。生物碱神经胺的四环基序是通过应用新开发的铜催化的CC偶联制备的。

  DOI：

  10.1021/jo502446k
• 作为产物：
  描述：

  potassium phtalimide 、 2-硝基苄溴 以 N,N-二甲基甲酰胺 为溶剂， 反应 12.0h， 以64%的产率得到2-(2-nitrobenzyl)isoindoline-1,3-dione
  参考文献：
  名称：

  [EN] 4- [HETEROCYCLYL-METHYL] -8-FLUORO-QUINOLIN-2-ONES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS
  [FR] 4-[HÉTÉROCYCLYLMÉTHYL]-8-FLUORO-QUINOLIN-2-ONES UTILES COMME INHIBITEURS DE L'OXYDE NITRIQUE SYNTHASE

  摘要：

  已发现具有式（II，III）的新化合物和药物组合物能够抑制可诱导型NOS合酶，其中：R4、R5、R6和R7分别选自氢、较低烷基和卤素组成的群；而R8具有结构，其中X1、X2、X3、X4、X5、X6、R9、R13、R14和n如本文所述。

  公开号：

  WO2009029625A1

文献信息

• Di-μ-hydroxy-bis(N,N,N′,N′-tetramethylenediamine)-copper(II) chloride [Cu(OH)·TMEDA]2Cl2: an efficient, practical catalyst for benzylation and allylation of amides
  作者：G. Kumaraswamy、A. Pitchaiah、G. Ramakrishna、D.S. Ramakrishna、K. Sadaiah

  DOI：10.1016/j.tetlet.2006.01.050

  日期：2006.3

  An efficient protocol for the benzylation or allylation of amides using the corresponding benzyl or allyl chlorides as electrophiles under basic conditions with commercially available 5 mol % of [Cu(OH)TMEDA]2Cl2 as catalyst was developed. Under these conditions, unprotected amino acids were benzylated without any racemization.

  开发了一种有效的方案，用于在碱性条件下使用相应的苄基或烯丙基氯作为亲电试剂，使用市售的5 mol％的[Cu（OH）TMEDA] 2 Cl 2作为催化剂，进行酰胺的苄基化或烯丙基化。在这些条件下，未保护的氨基酸被苄基化而没有外消旋作用。
• DIRECT INHIBITORS OF KEAP1-NRF2 INTERACTION AS ANTIOXIDANT INFLAMMATION MODULATORS
  申请人：Rutgers, The State University of New Jersey

  公开号：US20180148408A1

  公开（公告）日：2018-05-31

  A method of identifying compounds as direct inhibitors of Keap1-Nrf2 interaction through high-throughput screening and lead development. The direct inhibitors of Keap1-Nrf2 interaction are more specific and free of various undesirable effects than existing indirect inhibitors, and are potential drug candidates of chemopreventive and therapeutic agents for treatment of various diseases or conditions involving oxidative stress and/or inflammation, including but not limited to cancers, diabetes, Alzheimer's, and Parkinson's. Novel compounds are identified and methods of preventing or treating diseases or conditions related to Keap1-Nrf2 interaction activity by use of the novel compounds identified or compositions containing such compounds are also disclosed.

  通过高通量筛选和引物开发的方法，识别化合物作为Keap1-Nrf2相互作用的直接抑制剂。Keap1-Nrf2相互作用的直接抑制剂比现有的间接抑制剂更具特异性，不受各种不良影响，并且是化学预防和治疗各种涉及氧化应激和/或炎症的疾病或症状的潜在药物候选者，包括但不限于癌症、糖尿病、阿尔茨海默病和帕金森病。还公开了识别新化合物以及使用所识别的新化合物或含有这些化合物的组合物来预防或治疗与Keap1-Nrf2相互作用活性相关的疾病或症状的方法。
• Synthesis of 1,3,4,14b-tetrahydro-2<i>H</i>,10<i>H</i>-pyrazino[1,2-α]- pyrrolo[2,1-c][1,4]benzodiazepines
  作者：Avelina Ong-Lee、Leo Sylvester、Jan W. F. Wasley

  DOI：10.1002/jhet.5570200626

  日期：1983.11

  1,3,4,14b-Tetrahydro-2H,10H-pyrazino[1,2-α]pyrrolo[2,1-c] [1,4]benzodiazepines (1a-e) were synthesized to investigate their potential CNS activity. The key step in the synthesis was the formation of the 10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine (13) by reduction and concomitant cyclization of the nitroketone (11). Biological evaluation of 1a-e revealed interesting properties for 1b (CGS 7525A)

  合成了1,3,4,14b-四氢-2 H，10 H-吡嗪并[1,2-α]吡咯并[2,1-c] [1,4]苯并二氮杂（（1a-e）以研究其潜在的中枢神经系统活动。合成中的关键步骤是通过还原和伴随的硝基酮（11）环化形成10,11-dihydro-5 H-吡咯并[2,1-c] [1,4]苯并二氮杂ze（13）。1a-e的生物学评估显示了1b（CGS 7525A）的有趣特性[2]。
• [EN] DIRECT INHIBITORS OF KEAP1-NRF2 INTERACTION AS ANTIOXIDANT INFLAMMATION MODULATORS<br/>[FR] INHIBITEURS DIRECTS DE L'INTERACTION KEAP1-NRF2 EN TANT QUE MODULATEURS DE L'INFLAMMATION PAR ANTI-OXYDANT
  申请人：UNIV RUTGERS

  公开号：WO2013067036A1

  公开（公告）日：2013-05-10

  A method of identifying compounds as direct inhibitors of Keap1-Nrf2 interaction through high-throughput screening and lead development. The direct inhibitors of Keap1-Nrf2 interaction are more specific and free of various undesirable effects than existing indirect inhibitors, and are potential drug candidates of chemopreventive and therapeutic agents for treatment of various diseases or conditions involving oxidative stress and/or inflammation, including but not limited to cancers, diabetes, Alzheimer's, and Parkinson's. Novel compounds are identified and methods of preventing or treating diseases or conditions related to Keapl-Nrf2 interaction activity by use of the novel compounds identified or compositions containing such compounds are also disclosed.

  一种通过高通量筛选和引物开发将化合物识别为直接抑制Keap1-Nrf2相互作用的方法。Keap1-Nrf2相互作用的直接抑制剂比现有的间接抑制剂更具特异性，且不受各种不良效应的影响，是潜在的化学预防和治疗剂的候选药物，可用于治疗涉及氧化应激和/或炎症的各种疾病或病症，包括但不限于癌症、糖尿病、阿尔茨海默病和帕金森病。还披露了识别新化合物和利用所识别的新化合物或含有这些化合物的组合物预防或治疗与Keap1-Nrf2相互作用活性相关的疾病或病症的方法。
• Benzylphthalimides and Phenethylphthalimides with Thalidomide-Like Activity on the Production of Tumor Necrosis Factor .ALPHA..
  作者：Keizo SASAKI、Yoshihiro SHIBATA、Yuichi HASHIMOTO、Shigeo IWASAKI

  DOI：10.1248/bpb.18.1228

  日期：——

  Benzylphthalimide analogs (P1P's) and phenethylphthalimide analogs (P2P's) have been found to exhibit thalidomide-like activity on the production of tumor necrosis factor (TNF)-α by the human leukemia cell line, HL-60, stimulated by 12-O-tetradecanoylphorbol-13-acetate (TPA). Structure-activity relationships are discussed on the basis of the TNF-α production-enhancing activity. Benzylphthalimide (P1P-00) exhibited activity which is weaker than that of thalidomide, but introduction of a methyl group at the ortho-position of the benzyl moiety (P1P-10) resulted an increase to a level comparable with that of thalidomide. Phenethylphthalimide (P2P-00) is more potent than thalidomide, and its fluorinated derivative, 2-phenethyl-4, 5, 6, 7-tetrafluoro-1H-isoindole-1, 3-dione (FP2P-00), exhibited potent activity at very low concentrations.

  苄基邻苯二甲酰亚胺类化合物（P1P's）和苯乙基邻苯二甲酰亚胺类化合物（P2P's）被发现能够在通过12-O-十四酸酯磷酸酯（TPA）刺激的人类白血病细胞系HL-60中表现出类沙利度胺的活性，促进肿瘤坏死因子（TNF）-α的产生。基于TNF-α产生增强活性，讨论了结构-活性关系。苄基邻苯二甲酰亚胺（P1P-00）表现出的活性弱于沙利度胺，但在苄基的邻位引入甲基（P1P-10）后，其活性增强至与沙利度胺相当的水平。苯乙基邻苯二甲酰亚胺（P2P-00）的活性比沙利度胺更强，其氟化衍生物2-苯乙基-4, 5, 6, 7-四氟-1H-异苯并吡咯-1, 3-二酮（FP2P-00）在极低浓度下表现出强效活性。